Proqr Therapeutics (PRQR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 14,591 | 13,820 | 12,698 | 3,699 | 18,181 |
| Operating Income | -14,591 | -13,820 | -12,698 | -3,699 | -18,181 |
| Other Income | -612 | -1,695 | -2,633 | -825 | 443 |
| Pre-tax Income | -15,204 | -15,515 | -15,330 | -4,523 | -17,737 |
| Income Tax | 8 | 42 | 88 | 12 | N/A |
| Net Income Continuous | -15,212 | -15,557 | -15,418 | -4,535 | -17,737 |
| Minority Interests | -13 | -14 | -9 | -8 | -25 |
| Net Income | $-15,199 | $-15,543 | $-15,409 | $-4,528 | $-17,712 |
| EPS Basic Total Ops | -0.30 | -0.32 | -0.30 | -0.09 | -0.35 |
| EPS Basic Continuous Ops | -0.30 | -0.31 | -0.31 | -0.09 | -0.36 |
| EPS Diluted Total Ops | -0.30 | -0.32 | -0.30 | -0.09 | -0.35 |
| EPS Diluted Continuous Ops | -0.30 | -0.31 | -0.31 | -0.09 | -0.36 |
| EBITDA(a) | $-13,831 | $-13,121 | $-11,865 | $-3,116 | $-17,605 |